Swedencare AB (publ) has carried out a primary issuance of shares of approximately SEK 3.6 billion to Swedish and international institutional investors. The subscription price of SEK 100 was determined through an accelerated bookbuilding procedure.
Swedencare specializes in pet healthcare and produces, markets and sells premium products in the global and fast-growing market. The company has a wide range of strong brands and products within most therapy areas. Swedencare’s headquarter is in Malmö, Sweden with subsidiaries located in eight countries with products sold in approximately fifty markets.
The proceeds from the transaction will be used to partially finance the acquisitions of The Garmon Corporation and Innovet Italia Srl.
Pareto Securities and SEB acted as Joint Bookrunners. Baker McKenzie acted as legal advisor to the Joint Bookrunners with an international Capital Markets team consisting of Joakim Falkner and Per Blom in Stockholm as well as Adam Farlow and Charles Farnsworth in London.